New Year Honour for pioneering research
Congratulations to our NIHR Cambridge CRF Director, Professor Krishna Chatterjee, who has been awarded a CBE in the King’s New Year Honours for his groundbreaking work on endocrine disorders.
Leading the COVBOOST vaccine trial during the pandemic at Cambridge University Hospitals NHS Foundation Trust (CUH), Krishna Chatterjee is also a professor of endocrinology at the University of Cambridge. He is well known for discoveries of genetic disorders of thyroid gland formation, the regulation of hormone synthesis and hormone action. These have changed our understanding of the hypothalamic-pituitary-thyroid axis.
“I am delighted that our work has been recognised in this way. This also represents the efforts of many clinical and scientist colleagues in the University, CUH and our NIHR Clinical Research Facility, with whom I have worked over many years.
“Together with the patients participating in our research, we strive to continue advancing knowledge and health outcomes in endocrine disorders.” Professor Krishna Chatterjee
Prof Chatterjee’s research group is focused on genetic and molecular endocrinology, exploring disorders including resistance to thyroid hormone (RTH) and PPARgamma gene defects associated with lipodystrophic insulin resistance.
Prof Chatterjee showed how deficiency of human selenocysteine-containing proteins leads to a multisystem disease, including disordered thyroid hormone metabolism, and works on translating his discoveries to improve diagnosis and treatment of thyroid conditions.
Watch Owen’s story below:
Related articles: Newborns to get rapid genetic diagnostic testing